rdf:type |
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0007226,
umls-concept:C0035647,
umls-concept:C0039593,
umls-concept:C0060323,
umls-concept:C0205262,
umls-concept:C0231449,
umls-concept:C0332189,
umls-concept:C0332240,
umls-concept:C0441471,
umls-concept:C1522577,
umls-concept:C1524063,
umls-concept:C1861172,
umls-concept:C2603343,
umls-concept:C2917212,
umls-concept:C2926735
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-10-23
|
pubmed:abstractText |
The PROLONG study showed that D-dimer (D-d) testing could help tailor the duration of anticoagulation after idiopathic venous thromboembolism (VTE). In this report the initial 18 month study follow-up was extended for 1 year.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1573-742X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
381-8
|
pubmed:meshHeading |
pubmed-meshheading:19288181-Adolescent,
pubmed-meshheading:19288181-Adult,
pubmed-meshheading:19288181-Aged,
pubmed-meshheading:19288181-Aged, 80 and over,
pubmed-meshheading:19288181-Anticoagulants,
pubmed-meshheading:19288181-Cardiovascular Diseases,
pubmed-meshheading:19288181-Diagnostic Tests, Routine,
pubmed-meshheading:19288181-Drug Administration Schedule,
pubmed-meshheading:19288181-Female,
pubmed-meshheading:19288181-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:19288181-Follow-Up Studies,
pubmed-meshheading:19288181-Humans,
pubmed-meshheading:19288181-Male,
pubmed-meshheading:19288181-Middle Aged,
pubmed-meshheading:19288181-Neoplasms,
pubmed-meshheading:19288181-Occult Blood,
pubmed-meshheading:19288181-Risk Factors,
pubmed-meshheading:19288181-Time Factors,
pubmed-meshheading:19288181-Treatment Outcome,
pubmed-meshheading:19288181-Venous Thromboembolism,
pubmed-meshheading:19288181-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.
|
pubmed:affiliation |
Department Angiology and Blood Coagulation Marino Golinelli, S. Orsola-Malpighi University Hospital, Via Albertoni, 15, Bologna, Italy. benilde.cosmi@unibo.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|